Theme

Crystal Amber Fund Limited

CRSFinancial Services
151.00GBX
0.00%
Market Cap
95.01M
Volume
10.11k
16% of avg
P/E Ratio
NaN
EPS (TTM)
Beta
0.41
Day Range
0.00p - 0.00p
52 Week Range
0.00p151.00p159.00p
151.00p

Upcoming Events

Q1 2026
Anticipated update on Morphic Medical Inc.'s FDA approval process
High Impact Event
October 2026
Expected release of next annual results
High Impact Event
H2 2027
Estimated FDA approval for Morphic Medical Inc. RESET® device in the US
High Impact Event
CRS
NEUTRAL

Crystal Amber Fund Announces Share Buyback Programme

The investment fund announces a share buyback programme to repurchase up to £3 million or 1.8 million of its own shares.

CRS
NEUTRAL

Crystal Amber Fund Reports Mixed Results with NAV Growth and Portfolio Concentration

The investment fund reported a slight increase in NAV per share, but faced an overall loss and decreased total NAV. A successful exit and regulatory approval for a key holding were offset by portfolio concentration risks.

CRS
NEUTRAL

Crystal Amber Fund Hosts Investor Presentation for Morphic Medical

The investment fund is hosting an online investor presentation for Morphic Medical, a medical device company it owns a majority stake in.

CRS
NEUTRAL

Morphic Medical to Host Investor Presentation

The medical device company will be hosting an investor presentation, providing an opportunity for existing and potential shareholders to learn more about the business.

CRS
NEUTRAL

Morphic Medical Appoints New CFO

The medical device company has appointed a new Chief Financial Officer with extensive experience in the industry.

CRS
NEUTRAL

Morphic Medical's RESET obesity treatment achieves UK regulatory approval

The medical device company has received regulatory approval to sell its innovative obesity and diabetes treatment in the UK market.

CRS
NEUTRAL

Morphic Medical Appoints New CEO

The medical device company has appointed a new Chief Executive with experience in the bariatric endoscopy space.

CRS
NEUTRAL

Crystal Amber Fund Announces Share Buyback Programme

The investment fund announces a share buyback programme to repurchase up to £2.5 million of its own shares.

CRS
NEUTRAL

Crystal Amber Fund Limited Announces Holding Change

The major shareholder of this investment fund has increased its stake, but no further details are provided.

CRS
NEUTRAL

Crystal Amber Fund Announces Director Share Sale

The investment manager of the Crystal Amber Fund has sold a portion of its shareholding in the company.